• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

老年人房颤的跌倒风险与抗凝治疗:微妙的平衡。

Fall risk and anticoagulation for atrial fibrillation in the elderly: A delicate balance.

机构信息

Fellow in Cardiology, Washington University School of Medicine, St. Louis, MO, USA.

Director, Cardiac Rapid Evaluation Unit, Barnes-Jewish Hospital, St. Louis, MO, USA.

出版信息

Cleve Clin J Med. 2017 Jan;84(1):35-40. doi: 10.3949/ccjm.84a.16016.

DOI:10.3949/ccjm.84a.16016
PMID:28084982
Abstract

Guidelines for managing atrial fibrillation recommend systemic anticoagulation for almost all patients age 65 and older, but in practice up to 50% of older patients do not receive maintenance anticoagulation therapy. The most common reason physicians cite for withholding anticoagulation in older patients with atrial fibrillation is a perception of a high risk of falling and associated bleeding, especially intracranial hemorrhage.

摘要

心房颤动管理指南建议几乎所有 65 岁及以上的患者进行全身抗凝治疗,但实际上,多达 50%的老年患者未接受维持抗凝治疗。医生在老年心房颤动患者中拒绝抗凝的最常见原因是认为跌倒风险高且相关出血风险高,尤其是颅内出血。

相似文献

1
Fall risk and anticoagulation for atrial fibrillation in the elderly: A delicate balance.老年人房颤的跌倒风险与抗凝治疗:微妙的平衡。
Cleve Clin J Med. 2017 Jan;84(1):35-40. doi: 10.3949/ccjm.84a.16016.
2
Use of anticoagulation in elderly patients with atrial fibrillation who are at risk for falls.在有跌倒风险的老年房颤患者中使用抗凝治疗。
Ann Pharmacother. 2008 Apr;42(4):523-32. doi: 10.1345/aph.1K498. Epub 2008 Mar 11.
3
[Anticoagulation for atrial fibrillation in the patient at risk for falls].[对有跌倒风险的房颤患者进行抗凝治疗]
Rev Med Suisse. 2015 Oct 14;11(490):1899-900, 1902-3.
4
Anticoagulation of elderly patients at high risk for falls with atrial fibrillation.对有跌倒高风险的老年房颤患者进行抗凝治疗。
Med Lett Drugs Ther. 2017 Feb 27;59(1515):35-36.
5
Prior history of falls and risk of outcomes in atrial fibrillation: the Loire Valley Atrial Fibrillation Project.跌倒既往史与心房颤动的预后风险:卢瓦尔河谷心房颤动项目
Am J Med. 2014 Oct;127(10):972-8. doi: 10.1016/j.amjmed.2014.05.035. Epub 2014 Jun 12.
6
Clinical Stroke prevention in atrial fibrillation.心房颤动的临床卒中预防
J R Coll Physicians Edinb. 2017 Mar;47(1):13-23. doi: 10.4997/JRCPE.2017.105.
7
Anticoagulation therapy in elderly patients with atrial fibrillation: results from the Registry of Atrial Fibrillation To Investigate the Implementation of New Guidelines (RAFTING).老年心房颤动患者的抗凝治疗:心房颤动新指南实施调查登记研究(RAFTING)的结果
J Cardiovasc Med (Hagerstown). 2017 Jul;18(7):545-549. doi: 10.2459/JCM.0000000000000355.
8
Ischemic stroke and intracranial hemorrhage with aspirin, dabigatran, and warfarin: impact of quality of anticoagulation control.阿司匹林、达比加群和华法林与缺血性卒中和颅内出血:抗凝控制质量的影响
Stroke. 2015 Jan;46(1):23-30. doi: 10.1161/STROKEAHA.114.006476. Epub 2014 Nov 18.
9
Predicting Major Bleeding in Ischemic Stroke Patients With Atrial Fibrillation.预测合并心房颤动的缺血性卒中患者的大出血情况。
Stroke. 2017 Nov;48(11):3142-3144. doi: 10.1161/STROKEAHA.117.019183. Epub 2017 Sep 20.
10
Prescription patterns of oral anticoagulants for patients with non-valvular atrial fibrillation: experience at a Japanese single institution.非瓣膜性心房颤动患者口服抗凝剂的处方模式:日本一家机构的经验。
Heart Vessels. 2016 Jun;31(6):957-62. doi: 10.1007/s00380-015-0694-9. Epub 2015 May 29.

引用本文的文献

1
Atrial fibrillation and the risk of bone fractures: A meta-analysis of prospective cohort studies.心房颤动与骨折风险:前瞻性队列研究的荟萃分析
Medicine (Baltimore). 2024 Dec 27;103(52):e41049. doi: 10.1097/MD.0000000000041049.
2
Global, regional, and national burden of atrial fibrillation and atrial flutter from 1990 to 2021: sex differences and global burden projections to 2046-a systematic analysis of the Global Burden of Disease Study 2021.1990年至2021年全球、区域和国家心房颤动和心房扑动负担:性别差异及到2046年的全球负担预测——全球疾病负担研究2021的系统分析
Europace. 2025 Feb 5;27(2). doi: 10.1093/europace/euaf027.
3
Investigating Falls Risk Awareness in Hospitals Using the Self-Awareness of Falls Risk Measure (SAFRM): Empirical Research Quantitative.
使用跌倒风险自我认知量表(SAFRM)调查医院中的跌倒风险意识:实证定量研究
Nurs Open. 2025 Jan;12(1):e70099. doi: 10.1002/nop2.70099.
4
Identifying Dementia Severity Among People Living With Dementia Using Administrative Claims Data.利用行政索赔数据识别痴呆患者的严重程度。
J Am Med Dir Assoc. 2024 Sep;25(9):105129. doi: 10.1016/j.jamda.2024.105129. Epub 2024 Jul 6.
5
Relationship between electronically monitored adherence to direct oral anticoagulants and ischemic or hemorrhagic events after an initial ischemic stroke-A case control study.首次缺血性卒中后电子监测的直接口服抗凝剂依从性与缺血或出血事件的关系——一项病例对照研究
PLoS One. 2024 Apr 25;19(4):e0301421. doi: 10.1371/journal.pone.0301421. eCollection 2024.
6
Development and Validation of an Intracranial Hemorrhage Risk Score in Older Adults with Atrial Fibrillation Treated with Oral Anticoagulant.口服抗凝剂治疗的老年房颤患者颅内出血风险评分的开发与验证
Clin Epidemiol. 2024 Apr 17;16:267-279. doi: 10.2147/CLEP.S438013. eCollection 2024.
7
Patient Characteristics Associated With Using Transcatheter Left Atrial Appendage Occlusion Versus Oral Anticoagulants for Atrial Fibrillation.与使用经导管左心耳封堵术与口服抗凝药物治疗心房颤动相关的患者特征。
Circ Cardiovasc Qual Outcomes. 2024 Mar;17(3):e010279. doi: 10.1161/CIRCOUTCOMES.123.010279. Epub 2024 Mar 5.
8
Direct Oral Anticoagulants in Special Patient Populations.特殊患者群体中的直接口服抗凝剂
J Clin Med. 2023 Dec 29;13(1):216. doi: 10.3390/jcm13010216.
9
Percutaneous Left Atrial Appendage Occlusion: What the Practising Physician Should Know.经皮左心耳封堵术:执业医师应了解的内容
Eur Cardiol. 2023 Sep 28;18:e57. doi: 10.15420/ecr.2023.18. eCollection 2023.
10
Anticoagulation for Nonvalvular Diseases in Patients with a Limited Prognosis #461.预后有限患者非瓣膜病的抗凝治疗#461
J Palliat Med. 2023 Aug;26(8):1147-1149. doi: 10.1089/jpm.2023.0083.